Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00452335
Status:
COMPLETED
Last Update Posted:
2019-12-17
First Post:
2007-03-26
Brief Title:
Safety and Efficacy of Lubiprostone in Pediatric Patients With Constipation
Sponsor:
Sucampo Pharma Americas LLC
Organization:
Mallinckrodt
Study Overview
Official Title:
A Multi-center Open-labeled Study of the Safety Efficacy and Pharmacokinetics of Lubiprostone in Pediatric Patients With Constipation
Status:
COMPLETED
Status Verified Date:
2016-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary purpose of this study is to evaluate the safety and efficacy of lubiprostone in a pediatric population with constipation including the pharmacokinetics of lubiprostone in a subset of patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None